Biosynthesis

Friendship, United States Founded: 1955 • Age: 71 yrs Acquired By Sun Pharma
Generic drugs are manufactured by Biosynthesis in the pharmaceutical sector.

About Biosynthesis

Biosynthesis is a Healthcare company based in Friendship (United States) founded in 1955, and was acquired by Sun Pharma in November 2016. Generic drugs are manufactured by Biosynthesis in the pharmaceutical sector. Its focus areas include Traditional Pharmaceuticals.

Company details

Biosynthesis was established in 1955 in Friendship, United States, within the pharmaceutical industry. Generic drugs are produced by the company to provide cost-effective alternatives to branded medications. Operations encompass formulation, synthesis, and quality control processes for various therapeutic categories. Distribution occurs primarily in domestic markets, with adherence to regulatory standards ensured throughout the supply chain. The domain biosintez.com supports online information access.

  • Headquarters Friendship, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Pharmacy
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website biosintez.com
  • Social Facebook
  • Acquired by Sun Pharma (Nov 2016)
Key Metrics

Investors in Biosynthesis

Biosynthesis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sun Pharma.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983sunpharma.comMumbai, India
Premium access

Investor details for Biosynthesis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Biosynthesis

1 people are tracked at Biosynthesis (1 in leadership).

NameRoleGroup
Dmitriy Vasilyevich Boldov
Chief Executive OfficerLeadership
Premium access

Complete people profiles for Biosynthesis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Biosynthesis

2 dated milestones of Biosynthesis across 61 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biosynthesis is founded.
  2. Exit Acquired by Sun Pharma.

Web traffic of Biosynthesis

The website of Biosynthesis (biosintez.com) receives about 6.3K visits a month and ranks #3,090,383 among all websites worldwide, #3,699 in Pharmacy.

  • Monthly visits
    6.3K

    ▼ 4.5% vs previous month

  • Unique visitors
    2.8K

    per month

  • Global rank
    #3,090,383

    among all websites

  • Category rank
    #3,699

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with Biosynthesis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
akrikhin.ru
akrikhin.ru
100%
#733,723–
polysan.ru
88%
12.6K#2,472,818View details
princessjournal.ru
princessjournal.ru
65%
–
belmedpreparaty.com
59%
#955,541View details
fptl.ru
fptl.ru
42%
–

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Biosynthesis (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biosynthesis

Premium access

Complete news archive for Biosynthesis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biosynthesis

Biosynthesis was founded in 1955.

Biosynthesis is headquartered in Friendship, United States.

Biosynthesis was established in 1955 in Friendship, United States, within the pharmaceutical industry. Generic drugs are produced by the company to provide cost-effective alternatives to branded medications. Operations encompass formulation, synthesis, and quality control processes for various therapeutic categories. Distribution occurs primarily in domestic markets, with adherence to regulatory standards ensured throughout the supply chain. The domain biosintez.com supports online information access.

Biosynthesis has 1 investor. Key investors include Sun Pharma.

Yes. Biosynthesis was acquired by Sun Pharma in November 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available